Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

The decentralized US science funding system, often seen as inefficient, is framed as a feature, not a bug. This 'free market' competition between agencies like DARPA and NSF fosters more innovation than China's top-down, centralized model, which has failed on key objectives like EUV lithography.

Related Insights

China's strength is long-term, systematic planning. America's countervailing advantage is its 'craziness'—the ability for its economy and culture to pivot chaotically and unpredictably on new paradigms like AI. This unpredictability stems from its 'heretics' and 'crazies,' not from its predictable bureaucracy, making it difficult for adversaries to plan against.

Attempting to beat China by mimicking its state-controlled industrial policies is a strategic failure. This approach politicizes the economy, breeds inefficiency, and plays to China's strengths. The U.S. wins by leveraging its own core advantage: out-innovating and out-competing through a market-driven system.

The most effective government role in innovation is to act as a catalyst for high-risk, foundational R&D (like DARPA creating the internet). Once a technology is viable, the government should step aside to allow private sector competition (like SpaceX) to drive down costs and accelerate progress.

Unlike the U.S. government's recent strategy of backing single "champions" like Intel, China's successful industrial policy in sectors like EVs involves funding numerous competing companies. This state-fostered domestic competition is a key driver of their rapid innovation and market dominance.

To combat scientific stagnation, the government is launching 'meta-science' units to experiment with funding. One trial, 'golden tickets,' allows individual peer reviewers to unilaterally fund bold, high-risk ideas, mirroring how VCs back outlier founders.

While China's top-down mandates for AI seem formidable, they create a creativity gap, reflected in high youth unemployment. The American system, which allows for creating 'silly' consumer apps, fosters a culture of innovation that is a key long-term advantage in the global tech race.

Faced with China's superior speed and cost in executing known science, the U.S. biotech industry cannot compete by simply iterating faster. Its strategic advantage lies in

The U.S. defense research agency DARPA funds moonshot projects it knows may fail. The real value comes from the secondary innovations and materials created along the way, which are often more impactful than the original goal.

Contrary to the Western perception of a monolithic state-run system, China fosters intense competition among its provinces. Provincial leaders are incentivized to outperform each other, leading to massive, parallel innovation in industries like EVs and solar, creating a brutally efficient ecosystem.

Attempting to hoard technology like a state secret is counterproductive for the US. The nation's true competitive advantage has always been its open society, which enables broad participation and bottom-up innovation. Competing effectively, especially in AI, means leaning into this openness, not trying to emulate closed, top-down systems.